Abuse
"Abuse" References in the ICD-10-CM Index to Diseases and Injuries
References in the ICD-10-CM Index to Diseases and Injuries applicable to the clinical term "abuse"
- Abuse
- adult - See: Maltreatment, adult;
- as reason for
- couple seeking advice (including offender) - Z63.0 Problems in relationship with spouse or partner
- as reason for
- alcohol (non-dependent) - F10.10 Alcohol abuse, uncomplicated
- counseling and surveillance - Z71.41 Alcohol abuse counseling and surveillance of alcoholic
- in remission (early) (sustained) - F10.11 Alcohol abuse, in remission
- with
- anxiety disorder - F10.180 Alcohol abuse with alcohol-induced anxiety disorder
- intoxication - F10.129 Alcohol abuse with intoxication, unspecified
- mood disorder - F10.14 Alcohol abuse with alcohol-induced mood disorder
- other specified disorder - F10.188 Alcohol abuse with other alcohol-induced disorder
- psychosis - F10.159 Alcohol abuse with alcohol-induced psychotic disorder, unspecified
- sexual dysfunction - F10.181 Alcohol abuse with alcohol-induced sexual dysfunction
- sleep disorder - F10.182 Alcohol abuse with alcohol-induced sleep disorder
- unspecified disorder - F10.19 Alcohol abuse with unspecified alcohol-induced disorder
- withdrawal - F10.139 Alcohol abuse with withdrawal, unspecified
- analgesics (non-prescribed) (over the counter) - F55.8 Abuse of other non-psychoactive substances
- antacids - F55.0 Abuse of antacids
- antidepressants - See: Abuse, drug, psychoactive NEC;
- anxiolytic - See: Abuse, drug, sedative;
- barbiturates - See: Abuse, drug, sedative;
- caffeine - See: Abuse, drug, stimulant NEC;
- cannabis, cannabinoids - See: Abuse, drug, cannabis;
- child - See: Maltreatment, child;
- cocaine - See: Abuse, drug, cocaine;
- drug NEC (non-dependent) - F19.10 Other psychoactive substance abuse, uncomplicated
- amphetamine type - See: Abuse, drug, stimulant NEC;
- analgesics (non-prescribed) (over the counter) - F55.8 Abuse of other non-psychoactive substances
- antacids - F55.0 Abuse of antacids
- antidepressants - See: Abuse, drug, psychoactive NEC;
- anxiolytics - See: Abuse, drug, sedative;
- barbiturates - See: Abuse, drug, sedative;
- caffeine - See: Abuse, drug, stimulant NEC;
- cannabis - F12.10 Cannabis abuse, uncomplicated
- in remission (early) (sustained) - F12.11 Cannabis abuse, in remission
- with
- anxiety disorder - F12.180 Cannabis abuse with cannabis-induced anxiety disorder
- intoxication - F12.129 Cannabis abuse with intoxication, unspecified
- other specified disorder - F12.188 Cannabis abuse with other cannabis-induced disorder
- psychosis - F12.159 Cannabis abuse with psychotic disorder, unspecified
- unspecified disorder - F12.19 Cannabis abuse with unspecified cannabis-induced disorder
- withdrawal - F12.13 Cannabis abuse with withdrawal
- cocaine - F14.10 Cocaine abuse, uncomplicated
- in remission (early) (sustained) - F14.11 Cocaine abuse, in remission
- with
- anxiety disorder - F14.180 Cocaine abuse with cocaine-induced anxiety disorder
- intoxication - F14.129 Cocaine abuse with intoxication, unspecified
- mood disorder - F14.14 Cocaine abuse with cocaine-induced mood disorder
- other specified disorder - F14.188 Cocaine abuse with other cocaine-induced disorder
- psychosis - F14.159 Cocaine abuse with cocaine-induced psychotic disorder, unspecified
- sexual dysfunction - F14.181 Cocaine abuse with cocaine-induced sexual dysfunction
- sleep disorder - F14.182 Cocaine abuse with cocaine-induced sleep disorder
- unspecified disorder - F14.19 Cocaine abuse with unspecified cocaine-induced disorder
- withdrawal - F14.13 Cocaine abuse, unspecified with withdrawal
- counseling and surveillance - Z71.51 Drug abuse counseling and surveillance of drug abuser
- hallucinogen - F16.10 Hallucinogen abuse, uncomplicated
- in remission (early) (sustained) - F16.11 Hallucinogen abuse, in remission
- with
- anxiety disorder - F16.180 Hallucinogen abuse with hallucinogen-induced anxiety disorder
- flashbacks - F16.183 Hallucinogen abuse with hallucinogen persisting perception disorder (flashbacks)
- intoxication - F16.129 Hallucinogen abuse with intoxication, unspecified
- mood disorder - F16.14 Hallucinogen abuse with hallucinogen-induced mood disorder
- other specified disorder - F16.188 Hallucinogen abuse with other hallucinogen-induced disorder
- perception disorder, persisting - F16.183 Hallucinogen abuse with hallucinogen persisting perception disorder (flashbacks)
- psychosis - F16.159 Hallucinogen abuse with hallucinogen-induced psychotic disorder, unspecified
- unspecified disorder - F16.19 Hallucinogen abuse with unspecified hallucinogen-induced disorder
- hashish - See: Abuse, drug, cannabis;
- herbal or folk remedies - F55.1 Abuse of herbal or folk remedies
- hormones - F55.3 Abuse of steroids or hormones
- hypnotics - See: Abuse, drug, sedative;
- in remission (early) (sustained) - F19.11 Other psychoactive substance abuse, in remission
- inhalant - F18.10 Inhalant abuse, uncomplicated
- in remission (early) (sustained) - F18.11 Inhalant abuse, in remission
- with
- anxiety disorder - F18.180 Inhalant abuse with inhalant-induced anxiety disorder
- dementia, persisting - F18.17 Inhalant abuse with inhalant-induced dementia
- intoxication - F18.129 Inhalant abuse with intoxication, unspecified
- mood disorder - F18.14 Inhalant abuse with inhalant-induced mood disorder
- other specified disorder - F18.188 Inhalant abuse with other inhalant-induced disorder
- psychosis - F18.159 Inhalant abuse with inhalant-induced psychotic disorder, unspecified
- unspecified disorder - F18.19 Inhalant abuse with unspecified inhalant-induced disorder
- laxatives - F55.2 Abuse of laxatives
- LSD - See: Abuse, drug, hallucinogen;
- marihuana - See: Abuse, drug, cannabis;
- morphine type (opioids) - See: Abuse, drug, opioid;
- opioid - F11.10 Opioid abuse, uncomplicated
- in remission (early) (sustained) - F11.11 Opioid abuse, in remission
- with
- intoxication - F11.129 Opioid abuse with intoxication, unspecified
- mood disorder - F11.14 Opioid abuse with opioid-induced mood disorder
- other specified disorder - F11.188 Opioid abuse with other opioid-induced disorder
- psychosis - F11.159 Opioid abuse with opioid-induced psychotic disorder, unspecified
- sexual dysfunction - F11.181 Opioid abuse with opioid-induced sexual dysfunction
- sleep disorder - F11.182 Opioid abuse with opioid-induced sleep disorder
- unspecified disorder - F11.19 Opioid abuse with unspecified opioid-induced disorder
- withdrawal - F11.13 Opioid abuse with withdrawal
- psychoactive NEC - F19.10 Other psychoactive substance abuse, uncomplicated
- with
- amnestic disorder - F19.16 Other psychoactive substance abuse with psychoactive substance-induced persisting amnestic disorder
- anxiety disorder - F19.180 Other psychoactive substance abuse with psychoactive substance-induced anxiety disorder
- dementia - F19.17 Other psychoactive substance abuse with psychoactive substance-induced persisting dementia
- intoxication - F19.129 Other psychoactive substance abuse with intoxication, unspecified
- mood disorder - F19.14 Other psychoactive substance abuse with psychoactive substance-induced mood disorder
- other specified disorder - F19.188 Other psychoactive substance abuse with other psychoactive substance-induced disorder
- psychosis - F19.159 Other psychoactive substance abuse with psychoactive substance-induced psychotic disorder, unspecified
- sexual dysfunction - F19.181 Other psychoactive substance abuse with psychoactive substance-induced sexual dysfunction
- sleep disorder - F19.182 Other psychoactive substance abuse with psychoactive substance-induced sleep disorder
- unspecified disorder - F19.19 Other psychoactive substance abuse with unspecified psychoactive substance-induced disorder
- withdrawal - F19.139 Other psychoactive substance abuse with withdrawal, unspecified
- with
- sedative, hypnotic or anxiolytic - F13.10 Sedative, hypnotic or anxiolytic abuse, uncomplicated
- in remission (early) (sustained) - F13.11 Sedative, hypnotic or anxiolytic abuse, in remission
- with
- anxiety disorder - F13.180 Sedative, hypnotic or anxiolytic abuse with sedative, hypnotic or anxiolytic-induced anxiety disorder
- intoxication - F13.129 Sedative, hypnotic or anxiolytic abuse with intoxication, unspecified
- mood disorder - F13.14 Sedative, hypnotic or anxiolytic abuse with sedative, hypnotic or anxiolytic-induced mood disorder
- other specified disorder - F13.188 Sedative, hypnotic or anxiolytic abuse with other sedative, hypnotic or anxiolytic-induced disorder
- psychosis - F13.159 Sedative, hypnotic or anxiolytic abuse with sedative, hypnotic or anxiolytic-induced psychotic disorder, unspecified
- sexual dysfunction - F13.181 Sedative, hypnotic or anxiolytic abuse with sedative, hypnotic or anxiolytic-induced sexual dysfunction
- sleep disorder - F13.182 Sedative, hypnotic or anxiolytic abuse with sedative, hypnotic or anxiolytic-induced sleep disorder
- unspecified disorder - F13.19 Sedative, hypnotic or anxiolytic abuse with unspecified sedative, hypnotic or anxiolytic-induced disorder
- withdrawal - F13.139 Sedative, hypnotic or anxiolytic abuse with withdrawal, unspecified
- solvent - See: Abuse, drug, inhalant;
- steroids - F55.3 Abuse of steroids or hormones
- stimulant NEC - F15.10 Other stimulant abuse, uncomplicated
- in remission (early) (sustained) - F15.11 Other stimulant abuse, in remission
- with
- anxiety disorder - F15.180 Other stimulant abuse with stimulant-induced anxiety disorder
- intoxication - F15.129 Other stimulant abuse with intoxication, unspecified
- mood disorder - F15.14 Other stimulant abuse with stimulant-induced mood disorder
- other specified disorder - F15.188 Other stimulant abuse with other stimulant-induced disorder
- psychosis - F15.159 Other stimulant abuse with stimulant-induced psychotic disorder, unspecified
- sexual dysfunction - F15.181 Other stimulant abuse with stimulant-induced sexual dysfunction
- sleep disorder - F15.182 Other stimulant abuse with stimulant-induced sleep disorder
- unspecified disorder - F15.19 Other stimulant abuse with unspecified stimulant-induced disorder
- withdrawal - F15.13 Other stimulant abuse with withdrawal
- tranquilizers - See: Abuse, drug, sedative;
- vitamins - F55.4 Abuse of vitamins
- with sleep disorder - F19.182 Other psychoactive substance abuse with psychoactive substance-induced sleep disorder
- hallucinogens - See: Abuse, drug, hallucinogen;
- hashish - See: Abuse, drug, cannabis;
- herbal or folk remedies - F55.1 Abuse of herbal or folk remedies
- hormones - F55.3 Abuse of steroids or hormones
- hypnotic - See: Abuse, drug, sedative;
- inhalant - See: Abuse, drug, inhalant;
- laxatives - F55.2 Abuse of laxatives
- LSD - See: Abuse, drug, hallucinogen;
- marihuana - See: Abuse, drug, cannabis;
- morphine type (opioids) - See: Abuse, drug, opioid;
- non-psychoactive substance NEC - F55.8 Abuse of other non-psychoactive substances
- antacids - F55.0 Abuse of antacids
- folk remedies - F55.1 Abuse of herbal or folk remedies
- herbal remedies - F55.1 Abuse of herbal or folk remedies
- hormones - F55.3 Abuse of steroids or hormones
- laxatives - F55.2 Abuse of laxatives
- steroids - F55.3 Abuse of steroids or hormones
- vitamins - F55.4 Abuse of vitamins
- opioids - See: Abuse, drug, opioid;
- physical (adult) (child) - See: Maltreatment;
- psychoactive substance - See: Abuse, drug, psychoactive NEC;
- psychological (adult) (child) - See: Maltreatment;
- sedative - See: Abuse, drug, sedative;
- sexual - See: Maltreatment;
- solvent - See: Abuse, drug, inhalant;
- steroids - F55.3 Abuse of steroids or hormones
- vitamins - F55.4 Abuse of vitamins
- adult - See: Maltreatment, adult;
Applicable Clinical Terms Definitions
Adult: A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available.
Antacids: Substances that counteract or neutralize acidity of the GASTROINTESTINAL TRACT.
Anxiety Disorders: Persistent and disabling ANXIETY.
Anti-Anxiety Agents: Agents that alleviate ANXIETY, tension, and ANXIETY DISORDERS, promote sedation, and have a calming effect without affecting clarity of consciousness or neurologic conditions. ADRENERGIC BETA-ANTAGONISTS are commonly used in the symptomatic treatment of anxiety but are not included here.
Barbiturates: A class of chemicals derived from barbituric acid or thiobarbituric acid. Many of these are GABA MODULATORS used as HYPNOTICS AND SEDATIVES, as ANESTHETICS, or as ANTICONVULSANTS.
Caffeine: A methylxanthine naturally occurring in some beverages and also used as a pharmacological agent. Caffeine's most notable pharmacological effect is as a central nervous system stimulant, increasing alertness and producing agitation. It also relaxes SMOOTH MUSCLE, stimulates CARDIAC MUSCLE, stimulates DIURESIS, and appears to be useful in the treatment of some types of headache. Several cellular actions of caffeine have been observed, but it is not entirely clear how each contributes to its pharmacological profile. Among the most important are inhibition of cyclic nucleotide PHOSPHODIESTERASES, antagonism of ADENOSINE RECEPTORS, and modulation of intracellular calcium handling.
Cannabis: The plant genus in the Cannabaceae plant family, Urticales order, Hamamelidae subclass. The flowering tops are called many slang terms including pot, marijuana, hashish, bhang, and ganja. The stem is an important source of hemp fiber.
Child: A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL.
Cocaine: An alkaloid ester extracted from the leaves of plants including coca. It is a local anesthetic and vasoconstrictor and is clinically used for that purpose, particularly in the eye, ear, nose, and throat. It also has powerful central nervous system effects similar to the amphetamines and is a drug of abuse. Cocaine, like amphetamines, acts by multiple mechanisms on brain catecholaminergic neurons; the mechanism of its reinforcing effects is thought to involve inhibition of dopamine uptake.
Delirium: A disorder characterized by CONFUSION; inattentiveness; disorientation; ILLUSIONS; HALLUCINATIONS; agitation; and in some instances autonomic nervous system overactivity. It may result from toxic/metabolic conditions or structural brain lesions. (From Adams et al., Principles of Neurology, 6th ed, pp411-2)
Delusions: A false belief regarding the self or persons or objects outside the self that persists despite the facts, and is not considered tenable by one's associates.
Dementia: An acquired organic mental disorder with loss of intellectual abilities of sufficient severity to interfere with social or occupational functioning. The dysfunction is multifaceted and involves memory, behavior, personality, judgment, attention, spatial relations, language, abstract thought, and other executive functions. The intellectual decline is usually progressive, and initially spares the level of consciousness.
Hallucinations: Subjectively experienced sensations in the absence of an appropriate stimulus, but which are regarded by the individual as real. They may be of organic origin or associated with MENTAL DISORDERS.
Hallucinogens: Drugs capable of inducing illusions, hallucinations, delusions, paranoid ideations, and other alterations of mood and thinking. Despite the name, the feature that distinguishes these agents from other classes of drugs is their capacity to induce states of altered perception, thought, and feeling that are not experienced otherwise.
Hormones: Chemical substances having a specific regulatory effect on the activity of a certain organ or organs. The term was originally applied to substances secreted by various ENDOCRINE GLANDS and transported in the bloodstream to the target organs. It is sometimes extended to include those substances that are not produced by the endocrine glands but that have similar effects.
Hypnotics and Sedatives: Drugs used to induce drowsiness or sleep or to reduce psychological excitement or anxiety.
Laxatives: Agents that produce a soft formed stool, and relax and loosen the bowels, typically used over a protracted period, to relieve CONSTIPATION.
Mood Disorders: Those disorders that have a disturbance in mood as their predominant feature.
Psychotic Disorders: Disorders in which there is a loss of ego boundaries or a gross impairment in reality testing with delusions or prominent hallucinations. (From DSM-IV, 1994)
Sleep Wake Disorders: Abnormal sleep-wake schedule or pattern associated with the CIRCADIAN RHYTHM which affect the length, timing, and/or rigidity of the sleep-wake cycle relative to the day-night cycle.
Steroids: A group of polycyclic compounds closely related biochemically to TERPENES. They include cholesterol, numerous hormones, precursors of certain vitamins, bile acids, alcohols (STEROLS), and certain natural drugs and poisons. Steroids have a common nucleus, a fused, reduced 17-carbon atom ring system, cyclopentanoperhydrophenanthrene. Most steroids also have two methyl groups and an aliphatic side-chain attached to the nucleus. (From Hawley's Condensed Chemical Dictionary, 11th ed)
Vitamins: Organic substances that are required in small amounts for maintenance and growth, but which cannot be manufactured by the human body.